Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeNYSE:JNJ

      NYSE:JNJ

      J&J  Q2 Earnings & Sales Top, EPS View Cut on M&A Costs
      Investing News

      J&J Q2 Earnings & Sales Top, EPS View Cut on M&A Costs

      July 17, 2024
      J&J Sells Remaining Stake in Spinoff Kenvue
      Investing News

      J&J Sells Remaining Stake in Spinoff Kenvue

      May 13, 2024
      Johnson & Johnson Stock Offers Attractive Value Opportunity
      Trading Tips

      Johnson & Johnson Stock Offers Attractive Value Opportunity

      October 3, 2023
      J&J’s Rybrevant Combination Succeeds in NSCLC Study 
      Investing News

      J&J’s Rybrevant Combination Succeeds in NSCLC Study 

      October 2, 2023
      J&J Anticipates Double-Digit Profit Surge in 2023 Following Kenvue Spinoff
      Investing News

      J&J Anticipates Double-Digit Profit Surge in 2023 Following Kenvue Spinoff

      August 30, 2023
      J&J Shares Poised for Largest Daily Decline in 3 Years Following Talc Setback
      Investing News

      J&J Shares Poised for Largest Daily Decline in 3 Years Following Talc Setback

      July 31, 2023
      Johnson & Johnson Posts Strong Q2 Earnings Driven by Diverse Portfolio Performance
      Investing News

      Johnson & Johnson Posts Strong Q2 Earnings Driven by Diverse Portfolio Performance

      July 21, 2023
      JNJ Stock: Is it Appealing at a 52-Week Low?
      Trading Tips

      JNJ Stock: Is it Appealing at a 52-Week Low?

      March 1, 2023
      Jnj Stock Closed Slightly Down as Received FDA Clearance for Its Multiple Myeloma Treatment
      Investing News

      Jnj Stock Closed Slightly Down as Received FDA Clearance for Its Multiple Myeloma Treatment

      October 25, 2022
      JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations 
      Uncategorized

      JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations 

      October 20, 2022
      1 2 3 »

       

      LATEST NEWS

      • Investing News MongoDB Q3 Earnings Surprise
      • Investing News HP to Cut 6,000 Jobs Amid Restructuring
      • Investing News Dell’s Q3 2026 Earnings Analysis
      • Investing News Workday Q3 Earnings Report 2026 Insights
      • Investing News Alibaba’s AI Boosts Cloud Sales

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025